title: Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma.
authors.affiliation: Department of Medicine, Division of Hematology and Oncology, University of California, San Francisco, California, USA. weiai@medicine.ucsf.edu
authors.forename: Weiyun Z
authors.initials: WZ
authors.lastname: Ai
authors.forename: Holbrook E K
authors.initials: HE
authors.lastname: Kohrt
authors.forename: John
authors.initials: J
authors.lastname: Timmerman
authors.forename: Jimmy
authors.initials: J
authors.lastname: Hwang
authors.forename: Frank J
authors.initials: FJ
authors.lastname: Hsu
authors.forename: Debra D
authors.initials: DD
authors.lastname: Czerwinski
authors.forename: Behnaz
authors.initials: B
authors.lastname: Taidi
authors.forename: Ronald
authors.initials: R
authors.lastname: Levy
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D006801:Humans; D016233:Immunotherapy, Active; D008224:Lymphoma, Follicular / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000633:toxicity; D014750:Vincristine / Q000008:administration & dosage; D055815:Young Adult
chemical_list: D014750:Vincristine; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine; D011241:Prednisone